Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35

Virology

Volumn 414, Issue 2, 2011, Pages 119-129

  Salsman, Jayme ^a   Wang, Xueqi ^a   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

CMV; Cytomegalovirus; Nuclear bodies; PML; Pp71; Promyelocytic leukemia; UL35; UL35a

Indexed keywords

DAXX PROTEIN; GENE PRODUCT; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN PP71; SP100 PROTEIN; UL35 PROTEIN; UL35A PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; VIRUS CELL INTERACTION;

CELL LINE, TUMOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTRANUCLEAR INCLUSION BODIES; NUCLEAR PROTEINS; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 79955880944     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.013     Document Type: Article

References (44)

1. Ahn J.H., Hayward G.S. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J. Virol. 1997, 71(6):4599-4613.
2. Ahn J.H., Hayward G.S. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 2000, 274(1):39-55.
3. Ambinder R.F., Mullen M.A., Chang Y.N., Hayward G.S., Hayward S.D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 1991, 65(3):1466-1478.
4. Bernardi R., Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8(12):1006-1016.
5. Cantrell S.R., Bresnahan W.A. Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J. Virol. 2005, 79(12):7792-7802.
6. Cantrell S.R., Bresnahan W.A. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 2006, 80(12):6188-6191.
7. Chelbi-Alix M.K., de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 1999, 18(4):935-941.
8. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 2009, 22(1):76-98. Table of Contents.
9. Dellaire G., Bazett-Jones D.P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004, 26(9):963-977.
10. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., Liu F. Functional profiling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. U.S.A. 2003, 100(24):14223-14228.
11. Everett R.D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., Parkinson J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 1998, 72(8):6581-6591.
12. Everett R.D., Maul G.G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 1994, 13(21):5062-5069.
13. Everett R.D., Murray J. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 2005, 79(8):5078-5089.
14. Everett R.D., Rechter S., Papior P., Tavalai N., Stamminger T., Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 2006, 80(16):7995-8005.
15. Hofmann H., Sindre H., Stamminger T. Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J. Virol. 2002, 76(11):5769-5783.
16. Hwang J., Kalejta R.F. Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 2007, 367(2):334-338.
17. Hwang J., Kalejta R.F. Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J. Virol. 2009, 83(13):6591-6598.
18. Ishov A.M., Stenberg R.M., Maul G.G. Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 1997, 138(1):5-16.
19. Kalejta R.F. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 2008, 72(2):249-265. table of contents.
20. Kalejta R.F., Bechtel J.T., Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 2003, 23(6):1885-1895.
21. Korioth F., Maul G.G., Plachter B., Stamminger T., Frey J. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 1996, 229(1):155-158.
22. Liu Y., Biegalke B.J. The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol. 2002, 76(5):2460-2468.
23. Lukashchuk V., Everett R.D. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J. Virol. 2010, 84(8):4026-4040.
24. Lukashchuk V., McFarlane S., Everett R.D., Preston C.M. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 2008, 82(24):12543-12554.
25. Nayyar V., Shire K., Frappier L. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1 binding protein 2 (EBP2). J. Cell Sci. 2009, 122:4341-4350.
26. Negorev D.G., Vladimirova O.V., Ivanov A., Rauscher F., Maul G.G. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. 2006, 80(16):8019-8029.
27. Nitzsche A., Paulus C., Nevels M. Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J. Virol. 2008, 82(22):11167-11180.
28. Preston C.M., Nicholl M.J. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol. 2006, 87(Pt 5):1113-1121.
29. Reeves M.B. Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res. 2010.
30. Saffert R.T., Kalejta R.F. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 2006, 80(8):3863-3871.
31. Salsman J., Zimmerman N., Chen T., Domagala M., Frappier L. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog. 2008, 4(7):e1000100.
32. Schierling K., Buser C., Mertens T., Winkler M. Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol. 2005, 79(5):3084-3096.
33. Schierling K., Stamminger T., Mertens T., Winkler M. Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J. Virol. 2004, 78(17):9512-9523.
34. Shen W., Westgard E., Huang L., Ward M.D., Osborn J.L., Chau N.H., Collins L., Marcum B., Koach M.A., Bibbs J., Semmes O.J., Kerry J.A. Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein. Virology 2008, 376(1):42-52.
35. Sinclair J. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 2010, 1799(3-4):286-295.
36. Sinclair J., Sissons P. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 2006, 87(Pt 7):1763-1779.
37. Sivachandran N., Cao J.Y., Frappier L. Epstein-Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 2010, 84(21):11113-11123.
38. Sivachandran N., Sarkari F., Frappier L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 2008, 4(10):e1000170.
39. Tavalai N., Papior P., Rechter S., Leis M., Stamminger T. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 2006, 80(16):8006-8018.
40. Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J., Pasa-Tolic L., Wang D., Camp D.G., Rodland K., Wiley S., Britt W., Shenk T., Smith R.D., Nelson J.A. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 2004, 78(20):10960-10966.
41. Winkler M., aus Dem Siepen T., Stamminger T. Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J. Virol. 2000, 74(17):8053-8064.
42. Woodhall D.L., Groves I.J., Reeves M.B., Wilkinson G., Sinclair J.H. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 2006, 281(49):37652-37660.
43. Wu H., Ceccarelli D.F.J., Frappier L. The DNA segregation mechanism of the Epstein-Barr virus EBNA1 protein. EMBO Rep. 2000, 1:140-144.
44. Zeghouf M., Li J., Butland G., Borkowska A., Canadien V., Richards D., Beattie B., Emili A., Greenblatt J.F. Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J. Proteome Res. 2004, 3(3):463-468.